Revenues of Atara Biotherapeutics, Inc. from 31 Dec 2023 to 31 Dec 2025
- Taxonomy & unit
- us-gaap: USD
- Description
- Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
- Summary
-
Atara Biotherapeutics, Inc. quarterly and annual Revenues in USD history and change rate from 31 Dec 2023 to 31 Dec 2025.
- Atara Biotherapeutics, Inc. Revenues for the quarter ending 31 Dec 2025 was $1,595,000, a 95% decline year-over-year.
- Atara Biotherapeutics, Inc. Revenues for the twelve months ending 31 Dec 2025 was $120,772,000, a 6.3% decline year-over-year.
- Atara Biotherapeutics, Inc. annual Revenues for 2025 was $120,772,000, a 6.3% decline from 2024.
- Atara Biotherapeutics, Inc. annual Revenues for 2024 was $128,940,000, a 1404% increase from 2023.
- Source SEC data
- View on sec.gov
Revenues, Trailing 12 Months (USD)
Revenues, Quarterly (USD)
Revenues, YoY Quarterly Change (%)
Revenues, Annual (USD)
Revenues, YoY Annual Change (%)
Atara Biotherapeutics, Inc. Quarterly Revenues (USD)
| Period | TTM Value | Value | YoY Chg | Change % | Start Date | End Date | Report | Filed | Fiscal Year | Fiscal Period |
|---|---|---|---|---|---|---|---|---|---|---|
| Q4 2025 | $120,772,000 | $1,595,000 | -$31,158,000 | -95% | 01 Oct 2025 | 31 Dec 2025 | 10-K | 16 Mar 2026 | 2025 | FY |
| Q3 2025 | $151,930,000 | $3,453,000 | -$36,737,000 | -91% | 01 Jul 2025 | 30 Sep 2025 | 10-Q | 12 Nov 2025 | 2025 | Q3 |
| Q2 2025 | $188,667,000 | $17,575,000 | -$11,065,000 | -39% | 01 Apr 2025 | 30 Jun 2025 | 10-Q | 11 Aug 2025 | 2025 | Q2 |
| Q1 2025 | $199,732,000 | $98,149,000 | +$70,792,000 | +259% | 01 Jan 2025 | 31 Mar 2025 | 10-Q | 15 May 2025 | 2025 | Q1 |
| Q4 2024 | $128,940,000 | $32,753,000 | 01 Oct 2024 | 31 Dec 2024 | 10-K | 16 Mar 2026 | 2025 | FY | ||
| Q3 2024 | $40,190,000 | 01 Jul 2024 | 30 Sep 2024 | 10-Q | 12 Nov 2025 | 2025 | Q3 | |||
| Q2 2024 | $28,640,000 | 01 Apr 2024 | 30 Jun 2024 | 10-Q | 11 Aug 2025 | 2025 | Q2 | |||
| Q1 2024 | $27,357,000 | 01 Jan 2024 | 31 Mar 2024 | 10-Q | 15 May 2025 | 2025 | Q1 |
Atara Biotherapeutics, Inc. Annual Revenues (USD)
| Period | Value | YoY Chg | Change % | Start Date | End Date | Report | Filed | Fiscal Year | Fiscal Period |
|---|---|---|---|---|---|---|---|---|---|
| 2025 | $120,772,000 | -$8,168,000 | -6.3% | 01 Jan 2025 | 31 Dec 2025 | 10-K | 16 Mar 2026 | 2025 | FY |
| 2024 | $128,940,000 | +$120,367,000 | +1404% | 01 Jan 2024 | 31 Dec 2024 | 10-K | 16 Mar 2026 | 2025 | FY |
| 2023 | $8,573,000 | 01 Jan 2023 | 31 Dec 2023 | 10-K | 07 Mar 2025 | 2024 | FY |
* An asterisk sign (*) next to the value indicates that the value is likely invalid.